CIK: 0002111609 · Show all filings
Period: Q4 2025
Filing Date: Feb 17, 2026
Total Value ($000): $87,455 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| PRAX | PRAXIS PRECISION MEDICINES I | 40,000 | $11,790 | 13.5% | $186.22 | 0.0% | COM NEW | 74006W207 |
| XERS | XERIS BIOPHARMA HOLDINGS INC | 800,000 | $6,280 | 7.2% | $7.87 | 0.0% | COM | 98422E103 |
| BMRN | BIOMARIN PHARMACEUTICAL INC | 100,000 | $5,943 | 6.8% | $54.44 | 0.0% | COM | 09061G101 |
| FOLD | AMICUS THERAPEUTICS INC | 360,000 | $5,126 | 5.9% | $9.82 | 0.0% | COM | 03152W109 |
| ACAD | ACADIA PHARMACEUTICALS INC | 160,000 | $4,274 | 4.9% | $23.90 | 0.0% | COM | 004225108 |
| ANNX | ANNEXON INC | 750,000 | $3,765 | 4.3% | $3.82 | 0.0% | COM | 03589W102 |
| NUVB | NUVATION BIO INC | 400,000 | $3,584 | 4.1% | $6.19 | 0.0% | COM CL A | 67080N101 |
| BBIO | BRIDGEBIO PHARMA INC | 36,000 | $2,754 | 3.1% | $65.64 | 0.0% | COM | 10806X102 |
| PTCT | PTC THERAPEUTICS INC | 36,000 | $2,735 | 3.1% | $72.67 | 0.0% | COM | 69366J200 |
| UTHR | UNITED THERAPEUTICS CORP DEL | 5,500 | $2,680 | 3.1% | $465.69 | 0.0% | COM | 91307C102 |
| BCRX | BIOCRYST PHARMACEUTICALS INC | 300,000 | $2,340 | 2.7% | $7.23 | 0.0% | COM | 09058V103 |
| PCVX | VAXCYTE INC | 50,000 | $2,307 | 2.6% | $44.73 | 0.0% | COM | 92243G108 |
| GMAB | GENMAB A/S | 70,000 | $2,156 | 2.5% | $30.80 | — | SPONSORED ADS | 372303206 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 100,000 | $2,101 | 2.4% | $17.45 | 0.0% | COM | 87164F105 |
| VSTM | VERASTEM INC | 270,000 | $2,084 | 2.4% | $8.91 | 0.0% | COM NEW | 92337C203 |
| TARS | TARSUS PHARMACEUTICALS INC | 24,000 | $1,965 | 2.2% | $74.67 | 0.0% | COM | 87650L103 |
| APOG | APOGEE ENTERPRISES INC | 25,000 | $1,887 | 2.2% | $37.45 | 0.0% | COM | 037598109 |
| ZNTL | ZENTALIS PHARMACEUTICALS INC | 1,320,000 | $1,782 | 2.0% | $1.46 | 0.0% | COM | 98943L107 |
| INSM | INSMED INC | 10,000 | $1,740 | 2.0% | $182.48 | 0.0% | COM PAR $.01 | 457669307 |
| CORT | CORCEPT THERAPEUTICS INC | 44,000 | $1,531 | 1.8% | — | — | Call | 218352102 |
| SLN | SILENCE THERAPEUTICS PLC | 240,000 | $1,459 | 1.7% | $6.08 | — | ADS | 82686Q101 |
| EWTX | EDGEWISE THERAPEUTICS INC | 58,000 | $1,439 | 1.6% | $20.07 | 0.0% | COM | 28036F105 |
| BEAM | BEAM THERAPEUTICS INC | 50,000 | $1,386 | 1.6% | $25.51 | 0.0% | COM | 07373V105 |
| ORIC | ORIC PHARMACEUTICALS INC | 160,000 | $1,309 | 1.5% | $11.51 | 0.0% | COM | 68622P109 |
| APLS | APELLIS PHARMACEUTICALS INC | 50,000 | $1,256 | 1.4% | $23.46 | 0.0% | COM | 03753U106 |
| DNLI | DENALI THERAPEUTICS INC | 70,000 | $1,156 | 1.3% | $16.88 | 0.0% | COM | 24823R105 |
| RARE | ULTRAGENYX PHARMACEUTICAL IN | 50,000 | $1,150 | 1.3% | $32.88 | 0.0% | COM | 90400D108 |
| ASND | ASCENDIS PHARMA A/S | 5,000 | $1,066 | 1.2% | $213.24 | — | SPONSORED ADR | 04351P101 |
| NAMS | NEWAMSTERDAM PHARMA COMPANY | 30,000 | $1,052 | 1.2% | $36.39 | 0.0% | ORDINARY SHARES | N62509109 |
| LXRX | LEXICON PHARMACEUTICALS INC | 880,000 | $1,012 | 1.2% | $1.37 | 0.0% | COM NEW | 528872302 |
| BHVN | BIOHAVEN LTD | 88,000 | $994 | 1.1% | $12.39 | 0.0% | COM | G1110E107 |
| DNTH | DIANTHUS THERAPEUTICS INC | 24,000 | $989 | 1.1% | $38.77 | 0.0% | COM | 252828108 |
| NKTR | NEKTAR THERAPEUTICS | 20,000 | $846 | 1.0% | $55.96 | 0.0% | COM NEW | 640268306 |
| IMTX | IMMATICS N.V | 80,000 | $840 | 1.0% | $10.09 | 0.0% | SHS | N44445109 |
| AGIO | AGIOS PHARMACEUTICALS INC | 30,000 | $817 | 0.9% | $35.08 | 0.0% | COM | 00847X104 |
| IMVT | IMMUNOVANT INC | 30,000 | $763 | 0.9% | $22.30 | 0.0% | COM | 45258J102 |
| OLMA | OLEMA PHARMACEUTICALS INC | 30,000 | $750 | 0.9% | $17.79 | 0.0% | COM | 68062P106 |
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | 12,000 | $348 | 0.4% | $25.60 | 0.0% | COM | 03969K108 |